Today is World Metastatic Colorectal Cancer Day, a day dedicated to raising awareness about the most advanced form of bowel cancer, also known as metastatic colorectal cancer or mCRC.
Although 98 percent of bowel cancer cases can be successfully treated if detected early, fewer than 40 percent are.
In fact, up to half of the those newly diagnosed with bowel cancer, each year will have advanced disease at diagnosis or will go on to develop it.
Once bowel cancer is metastatic, treatment options change.
Australia's Therapeutic Goods Administration (TGA) has today given Keytruda® (pembrolizumab) provisional approval for patients with unresectable or metastatic, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) bowel cancer.